BioWorld - Friday, February 13, 2026

BioWorld Science

Nov. 5, 2008

View Archived Issues

Genzyme reviews quarterly developments

Read More

Novel anti-HIV agents disclosed in recent patent literature

Read More

Recent Targacept and AstraZeneca patents disclose new agents for neurological disorders

Read More

Novel therapeutics for gastrointestinal disorders reported in recent RaQualia patent

Read More

Vertex reviews Q3 highlights

Read More

OSI presents OXA-01 at EORTC-NCI-AACR Symposium

Read More

PDGFRalpha antibody MEDI-575 characterized in vitro, in vivo

Read More

Phase II dose of anticancer agent CS-7017 selected

Read More

SGN-70 investigated for potential in autoimmune disorders

Read More

Novel tubulin inhibitor ALB-109564 active in xenograft studies

Read More

Halozyme initiates phase II trial of insulin with rHuPH20 in type 1 diabetes

Read More

Avineuro advances two potent small molecules for AD into clinical development

Read More

Xamiol launched in Europe for scalp psoriasis

Read More

Genzyme and Osiris sign strategic alliance for Prochymal and Chondrogen stem cell products

Read More

Acusphere and Cephalon sign exclusive worldwide license agreement for AI-525

Read More

MonoSol and Midatech sign agreement to develop therapeutic nanoparticles in thin film

Read More

Biotec initiates enrollment in second phase III study of SBG for diabetic ulcers

Read More

Posters detail discovery, preclinical investigation of Met kinase inhibitor BMS-777607

Read More

Antibacterial activity of new fluoroquinolone JNJ-Q2 described

Read More

First-in-human study of HIV protease inhibitor SPI-256 completed

Read More

HemaQuest receives orphan drug status for HQK-1001 for hemoglobin disorders

Read More